Anthony L. Gotter - Concepedia

Author

Anthony L. Gotter

Also Known As

A Gotter, A L Gotter, A.L. Gotter, Anthony Gotter, Anthony L Gotter, Anthony L. Gotter, Gotter, A.L., Gotter, Anthony L.

Publications

3.6K

Citations

H-Index

110

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Merck (Japan)Children's Hospital of Philadelphia University of Pennsylvania

About

Anthony L. Gotter is an author at United States Military Academy specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	29	2.1K
2	Social Sciences	9	9	626
3	Natural Sciences	7	7	537
4	Health Sciences	5	5	388
5	Allergy	1	1	18

Anthony L. Gotter

Publications

Citations

H-Index

Page 1

	Year	Citations
Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Journal of Neurogenetics Sleep DisordersSleep MedicineSleepMolecular PharmacologySleep Disorder	2011	266
Illuminating the Circadian Clock in Monarch Butterfly Migration Oren Froy, Anthony L. Gotter, Amy Casselman, Science BiologyBehavioral NeuroscienceTime-compensated Sun CompassMigratory Monarch ButterfliesEntomology	2003	222
A time-less function for mouse Timeless Anthony L. Gotter, Thomas F. Manganaro, David R. Weaver, Nature Neuroscience Temporal DynamicMotor ControlNeuroscienceRobot LearningTimed System	2000	178
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors Jie Yin, Kerim Babaoglu, Chad A. Brautigam, Nature Structural & Molecular Biology Human Ox1Signal TransductionMolecular PhysiologyBiochemistryLigand-binding Mechanism	2016	147
Mammalian TIMELESS and Tipin are Evolutionarily Conserved Replication Fork-associated Factors Anthony L. Gotter, Christine Suppa, Beverly S. Emanuel Journal of Molecular Biology BiologyGenome InstabilityNatural SciencesGeneticsGenomic Mechanism	2006	138
Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Neuropharmacology Molecular PharmacologyPharmacological CharacterizationMedicinePhysiologyNeuropharmacology	2011	123
Discovery of [(2<i>R</i>,5<i>R</i>)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties Paul J. Coleman, John D. Schreier, Christopher D. Cox, ChemMedChem Sleep DisordersNeurotransmitterPeptide SciencePharmacotherapyExperimental Pharmacology	2012	121
In Vitro Characterization of T-Type Calcium Channel Antagonist TTA-A2 and In Vivo Effects on Arousal in Mice Richard L. Kraus, Yuxing Li, Yun Gregan, Journal of Pharmacology and Experimental Therapeutics	2010	108
A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2 Anthony L. Gotter, Tamim H. Shaikh, Marcia L. Budarf, Human Molecular Genetics CytogeneticsGeneticsMolecular BiologyMolecular GeneticsGenomics	2003	103
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner, BMC Neuroscience	2013	93

Page 1